Sökresultat - "Penas EMM"

The t(11;14)(q13;q32)/CCND1-IGH translocation is a recurrent secondary genetic aberration in relapsed chronic lymphocytic leukemia

Schliemann, I, Oschlies, I, Nagel, I, Penas, EMM, Siebert, R, Sander, B

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusion.

Jayne S; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., López C; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Universitat de Barcelona, Barcelona, Spain., Put N; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, Hematology and Radiotherapy, Ziekenhuis Oost-Limburg, Genk, Belgium.; Limburgs Oncologisch Centrum, Genk, Belgium.; Faculty of Medicine and Life Sciences, UHasselt-Hasselt University, Diepenbeek, Belgium., Nagel I; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany., Lierman E; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium., Penas EMM; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany., Michaux L; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium., Ahearne MJ; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Walter HS; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Bens S; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Drewes C; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Szczepanowski M; Hematopathology Section, Christian-Albrechts-University Kiel, Kiel, Germany.; Second Medicine Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Schlesner M; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany., Rosenstiel P; Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany., Wlodarska I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK.

Journal Article , 2024

Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker.

Johansson P; Faculty of Medicine, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Virchowstr. 177, 45122, Essen, Germany. patricia.johansson@uk-essen.de., Laguna T; Computational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, 28049, Madrid, Spain. teresa.laguna@imdea.org., Ossowski J; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.; Institute of Human Genetics, Medical School Hannover (MHH), Hannover, Germany., Pancaldi V; Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, INSERM U1037, 31037, Toulouse, France.; Barcelona Supercomputing Center, 08034, Barcelona, Spain., Brauser M; Faculty of Medicine, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Virchowstr. 177, 45122, Essen, Germany., Dührsen U; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Keuneke L; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Queiros A; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, 08036, Barcelona, Spain., Richter J; Institute for Pathology, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Martín-Subero JI; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, 08036, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Spain., Siebert R; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.; Institute of Human Genetics, University of Ulm and University Medical Center Ulm, Ulm, Germany., Schlegelberger B; Institute of Human Genetics, Medical School Hannover (MHH), Hannover, Germany., Küppers R; Faculty of Medicine, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Virchowstr. 177, 45122, Essen, Germany., Dürig J; Department of Internal Medicine, University Hospital Essen, St. Josef-Krankenhaus, University Medicine Essen, Essen, Germany., Penas EMM; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Pau ECS; Computational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, 28049, Madrid, Spain., Bergmann AK; Institute of Human Genetics, Medical School Hannover (MHH), Hannover, Germany.

Published Erratum , 2023

Molecular- and cytogenetic characterization of the IGH associated t (1;14) in a nodal marginal zone B-cell lymphoma case.

Akyüz N; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Penas EMM; Institute of Human Genetics, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany., Janjetovic S; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Loges S; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bokemeyer C; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Dierlamm J; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Letter; Research Support, Non-U.S. Gov't , 2021

ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells.

Kaehler M; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Dworschak M; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Rodin JP; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Ruemenapp J; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Vater I; Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel Germany., Penas EMM; Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel Germany., Liu C; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Cascorbi I; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Electronic address: cascorbi@pharmakologie.uni-kiel.de., Nagel I; Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; Institute of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel Germany.

Journal Article; Research Support, Non-U.S. Gov't , 2021